Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is likely an important TF in the pathogenesis of DN, and it is activated by both metabolic and hemodynamic alterations caused by diabetes (Suryavanshi and Kulkarni, 2017). This evidence concerns the gene NFKB1 and liver dysplastic nodule.